 Neuroleptic use parkinsonian symptoms tardive dyskinesia associated factors child adolescent psychiatric patients OBJECTIVE authors goal prevalence risk factors neuroleptic-induced movement disorders group children adolescents METHOD presence absence parkinsonism tardive dyskinesia akathisia children adolescents residence period state-operated child psychiatric center standardized structured assessment procedure research adult geriatric psychiatric patients retarded RESULTS prevalence parkinsonism subjects risk neuroleptic treatment periods evaluation prevalence treatment-emergent tardive dyskinesia subjects risk association quantitative neuroleptic treatment variables patients tardive dyskinesia likely family history mental illness likely history assaultive behavior pattern complex pharmacological responses parkinsonism tardive dyskinesia typical adults group young patients CONCLUSIONS study data acute sensitivity neuroleptic-treated child adolescent development parkinsonism possible role certain patient characteristics vulnerability tardive dyskinesia possibility neuroleptic-induced side effects children adolescents ways adults data need systematic monitoring neuroleptic-treated child adolescent patients full range side effects